Kilian Eyerich

About me
Publications
Public outreach and news

About me

Visiting Professor of Dermatology and Venereology.

Articles

Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024;38(4):695-702

Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.

Wollenberg A; Simon D; Kulthanan K; Figueras-Nart I; Misery L; Tangsirisap N; Spina L; Lu N; Grond S; Eyerich K
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024;38(2):340-353

Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.

Eyerich K; Gooderham MJ; Silvestre JF; Shumack SP; Mendes-Bastos P; Aoki V; Ortoncelli M; Silverberg JI; Teixeira HD; Chen SH; Calimlim BM; Takemoto S; Sancho C; Fritz B; Irvine AD
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023;37(11):2284-2292

Histology-based classifier to distinguish early mycosis fungoides from atopic dermatitis.

Roenneberg S; Braun SA; Garzorz-Stark N; Stark SP; Muresan A-M; Schmidle P; Biedermann T; Guenova E; Eyerich K
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023;37(10):2016-2027

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Schäkel K; Reich K; Asadullah K; Pinter A; Jullien D; Weisenseel P; Paul C; Gomez M; Wegner S; Personke Y; Kreimendahl F; Chen Y; Angsana J; Leung MWL; Eyerich K
Article: AGING CELL. 2023;22(10):e13957

The impact of the cardiovascular component and somatic mutations on ageing.

Garger D; Meinel M; Dietl T; Hillig C; Garzorz-Stark N; Eyerich K; de Angelis MH; Eyerich S; Menden MP
Article: IMMUNOTHERAPY. 2023;15(13):975-980

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary.

Reich K; Thyssen JP; Blauvelt A; Eyerich K; Soong W; Rice ZP; Hong HC-H; Katoh N; Valenzuela F; DiBonaventura M; Bratt TA; Zhang F; Clibborn C; Rojo R; Valdez H; Kerkmann U
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023;89(3):478-485

Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up).

Blauvelt A; Ladizinski B; Prajapati VH; Laquer V; Fischer A; Eisman S; Hu X; Wu T; Calimlim BM; Kaplan B; Liu Y; Teixeira HD; Liu J; Eyerich K
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023;89(3):486-495

Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial.

Strober B; Paul C; Blauvelt A; Thaçi D; Puig L; Lebwohl M; White K; Vanvoorden V; Deherder D; Gomez NN; Eyerich K
Article: JAMA DERMATOLOGY. 2023;159(8):837-847

Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.

Lescoat A; Huang S; Carreira PE; Siegert E; de Vries-Bouwstra J; Distler JHW; Smith V; Del Galdo F; Anic B; Damjanov N; Rednic S; Ribi C; Bancel DF; Hoffmann-Vold A-M; Gabrielli A; Distler O; Khanna D; Allanore Y; EUSTAR collaborators
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2023;152(2):408-419

The neglected twin: Nummular eczema is a variant of atopic dermatitis with codominant TH2/TH17 immune response.

Böhner A; Jargosch M; Müller NS; Garzorz-Stark N; Pilz C; Lauffer F; Wang R; Roenneberg S; Zink A; Thomas J; Theis FJ; Biedermann T; Eyerich S; Eyerich K
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2023;143(8):1461-1469.e5

Gene Expression-Based Molecular Test as Diagnostic Aid for the Differential Diagnosis of Psoriasis and Eczema in Formalin-Fixed and Paraffin-Embedded Tissue, Microbiopsies, and Tape Strips.

Fischer F; Doll A; Uereyener D; Roenneberg S; Hillig C; Weber L; Hackert V; Meinel M; Farnoud A; Seiringer P; Thomas J; Anand P; Graner L; Schlenker F; Zengerle R; Jonsson P; Jargosch M; Theis FJ; Schmidt-Weber CB; Biedermann T; Howell M; Reich K; Eyerich K; Menden M; Garzorz-Stark N; Lauffer F; Eyerich S
Article: MICROBIOME. 2023;11(1):162

Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour.

Amar Y; Rogner D; Silva RL; Foesel BU; Ud-Dean M; Lagkouvardos I; Steimle-Grauer SA; Niedermeier S; Kublik S; Jargosch M; Heinig M; Thomas J; Eyerich S; Wikström JD; Schloter M; Eyerich K; Biedermann T; Köberle M
Article: DERMATOLOGIE. 2023;74(6):410-415

[Molecular diagnosis of hand eczema].

Technau-Hafsi K; Garzorz-Stark N; Eyerich K
Article: DERMATOLOGIE. 2023;74(6):402-409

[Hand eczema or psoriasis: update on the FB 323 study occupational dermatology cohort].

Bentz P; Eyerich K; Skudlik C; Schröder-Kraft C; Löffler H; Pföhler C; Leitz R; Thölken K; Weisshaar E
Article: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023;21(5):445-454

[Ekzematisierte Psoriasis - eine häufige, aber oft vernachlässigte Variante der Plaque-Psoriasis].

Lauffer F; Eyerich K
Article: SCIENCE TRANSLATIONAL MEDICINE. 2023;15(683):eabj3289

IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases.

Lavazais S; Jargosch M; Dupont S; Labéguère F; Menet C; Jagerschmidt C; Ohm F; Kupcsik L; Parent I; Cottereaux C; Marsais F; Oste L; Van de Water A; Christophe T; De Vos S; Fallon P; Lauffer F; Clément-Lacroix P; Eyerich K; Brys R
Article: DERMATOLOGY PRACTICAL & CONCEPTUAL. 2023;13(1):e2023016

Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis.

Balato A; Scala E; Eyerich K; Brembilla NC; Chiricozzi A; Sabat R; Ghoreschi K
Article: NATURE COMMUNICATIONS. 2022;13(1):7729

Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases.

Schäbitz A; Hillig C; Mubarak M; Jargosch M; Farnoud A; Scala E; Kurzen N; Pilz AC; Bhalla N; Thomas J; Stahle M; Biedermann T; Schmidt-Weber CB; Theis F; Garzorz-Stark N; Eyerich K; Menden MP; Eyerich S
Article: HUMAN GENOMICS. 2022;16(1):62

The integration of large-scale public data and network analysis uncovers molecular characteristics of psoriasis.

Federico A; Pavel A; Möbus L; McKean D; Del Giudice G; Fortino V; Niehues H; Rastrick J; Eyerich K; Eyerich S; van den Bogaard E; Smith C; Weidinger S; de Rinaldis E; Greco D
Article: BRITISH JOURNAL OF DERMATOLOGY. 2022;187(3):338-352

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).

Bieber T; Reich K; Paul C; Tsunemi Y; Augustin M; Lacour J-P; Ghislain P-D; Dutronc Y; Liao R; Yang FE; Brinker D; DeLozier AM; Meskimen E; Janes JM; Eyerich K; BREEZE-AD4 study group
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022;36(9):1467-1476

Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.

Ziehfreund S; Tizek L; Hangel N; Fritzsche M-C; Weidinger S; Smith C; Bryce PJ; Greco D; van den Bogaard EH; Flohr C; Rastrick Ucb J; Eyerich S; Buyx A; Conrad C; Eyerich K; Zink A
Article: LANCET. 2022;400(10348):273-282

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.

Reich K; Thyssen JP; Blauvelt A; Eyerich K; Soong W; Rice ZP; Hong HC-H; Katoh N; Valenzuela F; DiBonaventura M; Bratt TA; Zhang F; Clibborn C; Rojo R; Valdez H; Kerkmann U
Article: SCIENCE TRANSLATIONAL MEDICINE. 2022;14(644):eabm8059

Enabling precision monitoring of psoriasis treatment by optoacoustic mesoscopy.

Hindelang B; Nau T; Englert L; Berezhnoi A; Lauffer F; Darsow U; Biedermann T; Eyerich K; Aguirre J; Ntziachristos V
Article: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2022;20(3):287-295

Molecular diagnostics in dermatology: An online survey to study usage, obstacles and requirements in Germany.

Tizek L; Schuster B; Gebhardt C; Reich K; von Kiedrowski R; Biedermann T; Eyerich K; Zink A; Garzorz-Stark N
Article: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2022;20(3):287-296

Molekulardiagnostik in der Dermatologie: Eine Online-Umfrage zur Untersuchung von Nutzung, Hürden und Anforderungen in Deutschland.

Tizek L; Schuster B; Gebhardt C; Reich K; von Kiedrowski R; Biedermann T; Eyerich K; Zink A; Garzorz-Stark N
Article: WORLD ALLERGY ORGANIZATION JOURNAL. 2022;15(1):100625

Urban vs rural - Prevalence of self-reported allergies in various occupational and regional settings.

Tizek L; Redlinger E; Ring J; Eyerich K; Biedermann T; Zink A
Article: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2022;23(Suppl 1):65-71

Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey.

Reisner DV; Johnsson FD; Kotowsky N; Brunette S; Valdecantos W; Eyerich K
Article: DERMATOLOGY AND THERAPY. 2022;12(1):81-95

Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study.

Klein TM; Blome C; Kleyn CE; Conrad C; Sator PG; Ståhle M; Eyerich K; Radtke MA; Bundy C; Cordey M; Griffiths CEM; Augustin M
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022;36(1):84-90

Addictions in patients with atopic dermatitis: a cross-sectional pilot study in Germany.

Pilz AC; Durner V; Schielein MC; Schuster B; Beckmann J; Biedermann T; Eyerich K; Zink A
Article: BIOMEDICINES. 2021;9(11):1698

Bisphosphonates for the Treatment of Calcinosis Cutis-A Retrospective Single-Center Study.

Rauch L; Hein R; Biedermann T; Eyerich K; Lauffer F
Article: BMJ OPEN. 2021;11(9):e049822

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE).

Eyerich K; Weisenseel P; Pinter A; Schäkel K; Asadullah K; Wegner S; Muñoz-Elias EJ; Bartz H; Taut FJH; Reich K
Article: JAMA DERMATOLOGY. 2021;157(9):1047-1055

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.

Blauvelt A; Teixeira HD; Simpson EL; Costanzo A; De Bruin-Weller M; Barbarot S; Prajapati VH; Lio P; Hu X; Wu T; Liu J; Ladizinski B; Chu AD; Eyerich K
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(8):1686-1691

Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial.

Thaçi D; Soliman AM; Eyerich K; Pinter A; Sebastian M; Unnebrink K; Rubant S; Williams DA; Weisenseel P
Article: CELLS. 2021;10(7):1606

Keratinocytes Regulate the Threshold of Inflammation by Inhibiting T Cell Effector Functions.

Seiringer P; Eyerich S; Eyerich K; Dittlein D; Pilz AC; Scala E; Ring J; Behrendt H; Cavani A; Traidl-Hoffmann C
Article: ALLERGY. 2021;76(4):988-1009

EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis.

Agache I; Akdis CA; Akdis M; Brockow K; Chivato T; Del Giacco S; Eiwegger T; Eyerich K; Giménez-Arnau A; Gutermuth J; Guttman-Yassky E; Maurer M; Ogg G; Ong PY; O'Mahony L; Schwarze J; Warner A; Werfel T; Palomares O; Jutel M
Article: ALLERGY. 2021;76(4):1158-1172

Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins.

Lauffer F; Baghin V; Standl M; Stark SP; Jargosch M; Wehrle J; Thomas J; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K; Garzorz-Stark N
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(3):701-711

A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE).

Pinter A; Hoffmann M; Reich K; Augustin M; Kaplan K; Gudjónsdóttir SD; Delvin T; Mrowietz U; CHANGE investigator group
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(1):123-134

Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study.

Augustin M; Kleyn CE; Conrad C; Sator PG; Ståhle M; Eyerich K; Radtke MA; Bundy C; Mellars L; Greggio C; Cordey M; Koscielny V; Griffiths CEM
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2020;34 Suppl 7:3-18

Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019.

Luger T; Dirschka T; Eyerich K; Gollnick H; Gupta G; Lambert J; Micali G; Ochsendorf F; Ständer S; Traidl-Hoffmann C
Article: EXPERIMENTAL DERMATOLOGY. 2020;29(11):1088-1096

Generalized pustular psoriasis-Dawn of a new era in targeted immunotherapy.

Neuhauser R; Eyerich K; Boehner A
Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):257

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.

Allanore Y; Bozzi S; Terlinden A; Huscher D; Amand C; Soubrane C; Siegert E; Czirják L; Carreira PE; Hachulla E; Zanatta E; Li M; Airò P; Mendoza FA; Rosato E; Distler O; EUSTAR Collaborators
Article: CONTACT DERMATITIS. 2020;83(3):206-214

Optoacoustic mesoscopy shows potential to increase accuracy of allergy patch testing.

Hindelang B; Aguirre J; Berezhnoi A; He H; Eyerich K; Ntziachristos V; Biedermann T; Darsow U
Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2020;17(17):E6182-6182

The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany.

Wang R; Helf C; Tizek L; Neuhauser R; Eyerich K; Zink A; Eberlein B; Biedermann T; Brockow K; Boehner A
Article: BRITISH JOURNAL OF DERMATOLOGY. 2020;183(2):265-275

Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS).

Thaçi D; Pinter A; Sebastian M; Termeer C; Sticherling M; Gerdes S; Wegner S; Krampe S; Bartz H; Rausch C; Mensch A; Eyerich K
Article: RHEUMATOLOGY. 2020;59(8):2016-2023

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.

Mihai C; Distler O; Gheorghiu AM; Constantin PI; Dobrota R; Jordan S; Smith V; Hachulla E; Henes J; Siegert E; Vettori S; Müller-Ladner U; Matucci Cerinic M; Allanore Y; EUSTAR collaborators
Journal article: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2020;18(8):795-807

COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications

Schön MP; Berking C; Biedermann T; Buhl T; Erpenbeck L; Eyerich K; Eyerich S; Ghoreschi K; Goebeler M; Ludwig RJ; Schäkel K; Schilling B; Schlapbach C; Stary G; von Stebut E; Steinbrink K
Article: RHEUMATOLOGY. 2020;59(7):1684-1694

Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.

Jaeger VK; Tikly M; Xu D; Siegert E; Hachulla E; Airò P; Valentini G; Matucci Cerinic M; Distler O; Cozzi F; Carreira P; Allanore Y; Müller-Ladner U; Ananieva LP; Balbir-Gurman A; Distler JHW; Czirják L; Li M; Henes J; Jimenez SA; Smith V; Damjanov N; Denton CP; DelGaldo F; Saketkoo LA; Walker UA; and EUSTAR co-authors
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020;146(1):8-16

Mechanisms of skin autoimmunity: Cellular and soluble immune components of the skin.

Gudjonsson JE; Kabashima K; Eyerich K
Article: JOURNAL OF CLINICAL MEDICINE. 2020;9(6):E1818-1818

Always Online? Internet Addiction and Social Impairment in Psoriasis across Germany.

Schielein MC; Tizek L; Schuster B; Ziehfreund S; Liebram C; Eyerich K; Zink A
Article: NATURE IMMUNOLOGY. 2020;21(5):555-566

Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal.

Baumann T; Dunkel A; Schmid C; Schmitt S; Hiltensperger M; Lohr K; Laketa V; Donakonda S; Ahting U; Lorenz-Depiereux B; Heil JE; Schredelseker J; Simeoni L; Fecher C; Körber N; Bauer T; Hüser N; Hartmann D; Laschinger M; Eyerich K; Eyerich S; Anton M; Streeter M; Wang T; Schraven B; Spiegel D; Assaad F; Misgeld T; Zischka H; Murray PJ; Heine A; Heikenwälder M; Korn T; Dawid C; Hofmann T; Knolle PA; Höchst B
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2020;34(4):800-809

IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema.

Lauffer F; Jargosch M; Baghin V; Krause L; Kempf W; Absmaier-Kijak M; Morelli M; Madonna S; Marsais F; Lepescheux L; Albanesi C; Müller NS; Theis FJ; Schmidt-Weber C; Eyerich S; Biedermann T; Vandeghinste N; Steidl S; Eyerich K
Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):59

ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.

Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S; EUSTAR collaborators
Article: BRITISH JOURNAL OF DERMATOLOGY. 2020;182(1):67-75

Continued treatment with secukinumab is associated with high retention or regain of response.

Augustin M; Thaci D; Eyerich K; Pinter A; Radtke M; Lauffer F; Mrowietz U; Gerdes S; Pariser D; Lebwohl M; Sieder C; Melzer N; Reich K
Article: HAUTARZT. 2019;70(10):760-765

[Molecular diagnostics of hand eczema].

Garzorz-Stark N; Eyerich K
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(9):1242-1248

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.

Becker M; Graf N; Sauter R; Allanore Y; Curram J; Denton CP; Khanna D; Matucci-Cerinic M; de Oliveira Pena J; Pope JE; Distler O; EUSTAR Collaborators; EUSTAR Collaborators (numerical order of centres)
Article: ARTHRITIS & RHEUMATOLOGY. 2019;71(9):1553-1570

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.

Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E; EUSTAR Collaborators
Article: OPTICS LETTERS. 2019;44(17):4119-4122

Optical features of human skin revealed by optoacoustic mesoscopy in the visible and short-wave infrared regions.

Berezhnoi A; Aguirre J; Hindelang B; Garzorz-Stark N; Omar M; Darsow U; Eyerich K; Ntziachristos V
Article: ARCHIVES OF DERMATOLOGICAL RESEARCH. 2019;311(5):421-424

Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study.

Gasslitter I; Kirsten N; Augustin M; Torz K; Mrowietz U; Eyerich K; Puig L; Hoetzenecker W; Schütz-Bergmayr M; Weger W; Wolf P; Reider N; Ratzinger G; Papageorgiou K; Meier TO; Maul J-T; Anzengruber F; Navarini AA
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(7):979-987

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M; Boubaya M; Distler O; Smith V; Matucci-Cerinic M; Alegre Sancho JJ; Truchetet M-E; Braun-Moscovici Y; Iannone F; Novikov PI; Lescoat A; Siegert E; Castellví I; Airó P; Vettori S; De Langhe E; Hachulla E; Erler A; Ananieva L; Krusche M; López-Longo FJ; Distler JHW; Hunzelmann N; Hoffmann-Vold A-M; Riccieri V; Hsu VM; Pozzi MR; Ancuta C; Rosato E; Mihai C; Kuwana M; Saketkoo LA; Chizzolini C; Hesselstrand R; Ullman S; Yavuz S; Rednic S; Caimmi C; Bloch-Queyrat C; Allanore Y; for EUSTAR network
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(5):648-656

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W; Jordan S; Graf N; de Oliveira Pena J; Curram J; Allanore Y; Matucci-Cerinic M; Pope JE; Denton CP; Khanna D; Distler O; EUSTAR Collaborators
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2019;33(5):950-953

Variable response to low-dose naltrexone in patients with Darier disease: a case series.

Boehmer D; Eyerich K; Darsow U; Biedermann T; Zink A
Article: SCIENCE OF THE TOTAL ENVIRONMENT. 2019;653:190-199

Human exposure to airborne pollen and relationships with symptoms and immune responses: Indoors versus outdoors, circadian patterns and meteorological effects in alpine and urban environments.

Damialis A; Häring F; Gökkaya M; Rauer D; Reiger M; Bezold S; Bounas-Pyrros N; Eyerich K; Todorova A; Hammel G; Gilles S; Traidl-Hoffmann C
Article: SCIENCE TRANSLATIONAL MEDICINE. 2019;11(480):eaau0683

Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment.

Matthias J; Maul J; Noster R; Meinl H; Chao Y-Y; Gerstenberg H; Jeschke F; Gasparoni G; Welle A; Walter J; Nordström K; Eberhardt K; Renisch D; Donakonda S; Knolle P; Soll D; Grabbe S; Garzorz-Stark N; Eyerich K; Biedermann T; Baumjohann D; Zielinski CE
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2019;33(1):115-122

Is the humoral immunity dispensable for the pathogenesis of psoriasis?

Thomas J; Küpper M; Batra R; Jargosch M; Atenhan A; Baghin V; Krause L; Lauffer F; Biedermann T; Theis FJ; Eyerich K; Schmidt-Weber CB; Eyerich S; Garzorz-Stark N
Article: HAUTARZT. 2019;70(1):15-20

[Personalized medicine in the field of inflammatory skin diseases].

Garzorz-Stark N; Eyerich K
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2018;142(5):1643-1647.e12

Relations between epidermal barrier dysregulation and Staphylococcus species-dominated microbiome dysbiosis in patients with atopic dermatitis.

Altunbulakli C; Reiger M; Neumann AU; Garzorz-Stark N; Fleming M; Huelpuesch C; Castro-Giner F; Eyerich K; Akdis CA; Traidl-Hoffmann C
Article: ARTHRITIS & RHEUMATOLOGY. 2018;70(11):1829-1834

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.

Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA; EUSTAR coauthors
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2018;138(8):1785-1794

Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis.

Lauffer F; Jargosch M; Krause L; Garzorz-Stark N; Franz R; Roenneberg S; Böhner A; Mueller NS; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
Article: EXPERIMENTAL DERMATOLOGY. 2018;27(7):798-802

45th meeting of the Arbeitsgemeinschaft Dermatologische Forschung.

Loser K; Eming R; Eyerich K; Gebhardt C; Ludwig R; Baghin V; Baurecht H; Forsthuber A; Glodde N; Schmidt E; Schmidt T; Shridhar N; Simon B; Gaffal E
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2018;138(7):1555-1563

Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.

Vandeghinste N; Klattig J; Jagerschmidt C; Lavazais S; Marsais F; Haas JD; Auberval M; Lauffer F; Moran T; Ongenaert M; Van Balen M; Dupont S; Lepescheux L; Garcia T; Härtle S; Eyerich K; Fallon PG; Brys R; Steidl S
Article: PHOTOACOUSTICS. 2018;10:31-37

Assessing nailfold microvascular structure with ultra-wideband raster-scan optoacoustic mesoscopy.

Aguirre J; Hindelang B; Berezhnoi A; Darsow U; Lauffer F; Eyerich K; Biedermann T; Ntziachristos V
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2018;141(4):1320-1333.e11

Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects.

Garzorz-Stark N; Lauffer F; Krause L; Thomas J; Atenhan A; Franz R; Roenneberg S; Boehner A; Jargosch M; Batra R; Mueller NS; Haak S; Groß C; Groß O; Traidl-Hoffmann C; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
Article: HAUTARZT. 2018;69(3):191-196

[Pathogenesis of atopic dermatitis].

Scheerer C; Eyerich K
Article: BRITISH JOURNAL OF DERMATOLOGY. 2018;178(3):722-730

Sebocytes contribute to skin inflammation by promoting the differentiation of T helper 17 cells.

Mattii M; Lovászi M; Garzorz N; Atenhan A; Quaranta M; Lauffer F; Konstantinow A; Küpper M; Zouboulis CC; Kemeny L; Eyerich K; Schmidt-Weber CB; Törőcsik D; Eyerich S
Article: BRITISH JOURNAL OF DERMATOLOGY. 2018;178(3):768-775

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E
Article: BRITISH JOURNAL OF DERMATOLOGY. 2017;177(6):1671-1682

Sebum lipids influence macrophage polarization and activation.

Lovászi M; Mattii M; Eyerich K; Gácsi A; Csányi E; Kovács D; Rühl R; Szegedi A; Kemény L; Ståhle M; Zouboulis CC; Eyerich S; Törőcsik D
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(11):1897-1905

Mapping and predicting mortality from systemic sclerosis.

Elhai M; Meune C; Boubaya M; Avouac J; Hachulla E; Balbir-Gurman A; Riemekasten G; Airò P; Joven B; Vettori S; Cozzi F; Ullman S; Czirják L; Tikly M; Müller-Ladner U; Caramaschi P; Distler O; Iannone F; Ananieva LP; Hesselstrand R; Becvar R; Gabrielli A; Damjanov N; Salvador MJ; Riccieri V; Mihai C; Szücs G; Walker UA; Hunzelmann N; Martinovic D; Smith V; Müller CDS; Montecucco CM; Opris D; Ingegnoli F; Vlachoyiannopoulos PG; Stamenkovic B; Rosato E; Heitmann S; Distler JHW; Zenone T; Seidel M; Vacca A; Langhe ED; Novak S; Cutolo M; Mouthon L; Henes J; Chizzolini C; Mühlen CAV; Solanki K; Rednic S; Stamp L; Anic B; Santamaria VO; De Santis M; Yavuz S; Sifuentes-Giraldo WA; Chatelus E; Stork J; Laar JV; Loyo E; García de la Peña Lefebvre P; Eyerich K; Cosentino V; Alegre-Sancho JJ; Kowal-Bielecka O; Rey G; Matucci-Cerinic M; Allanore Y; EUSTAR group
Article: AMERICAN JOURNAL OF DERMATOPATHOLOGY. 2017;39(10):742-746

Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.

Franz R; Ritter N; Hein R; Biedermann T; Al-Sisi M; Eyerich K; Garzorz-Stark N; Andres C
Article: SCIENTIFIC REPORTS. 2017;7(1):10386

Motion correction in optoacoustic mesoscopy.

Schwarz M; Garzorz-Stark N; Eyerich K; Aguirre J; Ntziachristos V
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2017;31(8):1308-1315

Addiction: an underestimated problem in psoriasis health care.

Zink A; Herrmann M; Fischer T; Lauffer F; Garzorz-Stark N; Böhner A; Spinner CD; Biedermann T; Eyerich K
Article: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2017;15(3):359-360

Die Deutsche Dermatologische Gesellschaft (DDG) mit ihrer Arbeitsgemeinschaft Dermatologische Forschung (ADF) Leitlinien zum Umgang mit Forschungsdaten in der dermatologischen Forschung.

Eyerich K; von Stebut E
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017;137(1):18-25

Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

Brunner PM; Silverberg JI; Guttman-Yassky E; Paller AS; Kabashima K; Amagai M; Luger TA; Deleuran M; Werfel T; Eyerich K; Stingl G; Councilors of the International Eczema Council
Article: EXPERIMENTAL DERMATOLOGY. 2016;25(10):767-774

A novel molecular disease classifier for psoriasis and eczema.

Garzorz-Stark N; Krause L; Lauffer F; Atenhan A; Thomas J; Stark SP; Franz R; Weidinger S; Balato A; Mueller NS; Theis FJ; Ring J; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1743-1748

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.

Dobrota R; Maurer B; Graf N; Jordan S; Mihai C; Kowal-Bielecka O; Allanore Y; Distler O; EUSTAR coauthors
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2016;138(2):336-349

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

Werfel T; Allam J-P; Biedermann T; Eyerich K; Gilles S; Guttman-Yassky E; Hoetzenecker W; Knol E; Simon H-U; Wollenberg A; Bieber T; Lauener R; Schmid-Grendelmeier P; Traidl-Hoffmann C; Akdis CA
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(7):1285-1292

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA; EUSTAR coauthors
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2016;30(7):1136-1139

Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donor.

Garzorz N; Thomas J; Eberlein B; Haferlach C; Ring J; Biedermann T; Schmidt-Weber C; Eyerich K; Seifert F; Eyerich S
Article: BLOOD. 2016;127(25):3154-3164

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Toubiana J; Okada S; Hiller J; Oleastro M; Lagos Gomez M; Aldave Becerra JC; Ouachée-Chardin M; Fouyssac F; Girisha KM; Etzioni A; Van Montfrans J; Camcioglu Y; Kerns LA; Belohradsky B; Blanche S; Bousfiha A; Rodriguez-Gallego C; Meyts I; Kisand K; Reichenbach J; Renner ED; Rosenzweig S; Grimbacher B; van de Veerdonk FL; Traidl-Hoffmann C; Picard C; Marodi L; Morio T; Kobayashi M; Lilic D; Milner JD; Holland S; Casanova J-L; Puel A; International STAT1 Gain-of-Function Study Group
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(4):681-686

Digital ulcers predict a worse disease course in patients with systemic sclerosis.

Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M; EUSTAR co-authors
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):103-109

Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.

Avouac J; Walker UA; Hachulla E; Riemekasten G; Cuomo G; Carreira PE; Caramaschi P; Ananieva LP; Matucci-Cerinic M; Czirjak L; Denton C; Ladner UM; Allanore Y; EUSTAR collaborators*; EUSTAR collaborators
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):163-169

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

Elhai M; Avouac J; Walker UA; Matucci-Cerinic M; Riemekasten G; Airò P; Hachulla E; Valentini G; Carreira PE; Cozzi F; Balbir Gurman A; Braun-Moscovici Y; Damjanov N; Ananieva LP; Scorza R; Jimenez S; Busquets J; Li M; Müller-Ladner U; Kahan A; Distler O; Allanore Y; EUSTAR co-authors
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2015;29(12):2429-2435

Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases.

Garzorz N; Alsisi M; Todorova A; Atenhan A; Thomas J; Lauffer F; Ring J; Schmidt-Weber C; Biedermann T; Eyerich S; Eyerich K
Article: MICROVASCULAR RESEARCH. 2015;102:19-24

A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.

Ingegnoli F; Boracchi P; Gualtierotti R; Smith V; Cutolo M; Foeldvari I; EUSTAR co-authors
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2015;135(11):2862-2870

Interleukin-22 Promotes Wound Repair in Diabetes by Improving Keratinocyte Pro-Healing Functions.

Avitabile S; Odorisio T; Madonna S; Eyerich S; Guerra L; Eyerich K; Zambruno G; Cavani A; Cianfarani F
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1124-1131

Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.

Maurer B; Graf N; Michel BA; Müller-Ladner U; Czirják L; Denton CP; Tyndall A; Metzig C; Lanius V; Khanna D; Distler O; EUSTAR co-authors
Article: SCIENCE TRANSLATIONAL MEDICINE. 2014;6(244):244ra90

Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema.

Quaranta M; Knapp B; Garzorz N; Mattii M; Pullabhatla V; Pennino D; Andres C; Traidl-Hoffmann C; Cavani A; Theis FJ; Ring J; Schmidt-Weber CB; Eyerich S; Eyerich K
Article: ALLERGY. 2014;69(5):632-642

A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding.

Kretschmer A; Möller G; Lee H; Laumen H; von Toerne C; Schramm K; Prokisch H; Eyerich S; Wahl S; Baurecht H; Franke A; Claussnitzer M; Eyerich K; Teumer A; Milani L; Klopp N; Hauck SM; Illig T; Peters A; Waldenberger M; Adamski J; Reischl E; Weidinger S
Article: PLOS ONE. 2014;9(7):e101814

Allergic contact dermatitis in psoriasis patients: typical, delayed, and non-interacting.

Quaranta M; Eyerich S; Knapp B; Nasorri F; Scarponi C; Mattii M; Garzorz N; Harlfinger AT; Jaeger T; Grosber M; Pennino D; Mempel M; Schnopp C; Theis FJ; Albanesi C; Cavani A; Schmidt-Weber CB; Ring J; Eyerich K
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2013;131(2):562-570

IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients.

Pennino D; Bhavsar PK; Effner R; Avitabile S; Venn P; Quaranta M; Marzaioli V; Cifuentes L; Durham SR; Cavani A; Eyerich K; Chung KF; Schmidt-Weber CB; Eyerich S
Article: EUROPEAN JOURNAL OF DERMATOLOGY. 2012;22(6):781-784

Differential in situ expression of IL-17 in skin diseases.

Fischer-Stabauer M; Boehner A; Eyerich S; Carbone T; Traidl-Hoffmann C; Schmidt-Weber CB; Cavani A; Ring J; Hein R; Eyerich K
Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(8):1355-1360

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.

Meier FMP; Frommer KW; Dinser R; Walker UA; Czirjak L; Denton CP; Allanore Y; Distler O; Riemekasten G; Valentini G; Müller-Ladner U; EUSTAR Co-authors
Article: CHEMICAL IMMUNOLOGY AND ALLERGY. 2012;96:39-44

Th17 and Th22 in skin allergy.

Cavani A; Pennino D; Eyerich K
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2011;208(8):1635-1648

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

Liu L; Okada S; Kong X-F; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RMC; Blancas-Galicia L; Beas IMM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel P-R; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova J-L
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2011;365(3):231-238

Mutual antagonism of T cells causing psoriasis and atopic eczema.

Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2011;41(7):1894-1901

IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans.

Eyerich S; Wagener J; Wenzel V; Scarponi C; Pennino D; Albanesi C; Schaller M; Behrendt H; Ring J; Schmidt-Weber CB; Cavani A; Mempel M; Traidl-Hoffmann C; Eyerich K
Article: HAUTARZT. 2011;62(2):107-118

[Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Rodríguez E; Eyerich K; Weidinger S
Article: EUROPEAN JOURNAL OF DERMATOLOGY. 2010;20(6):724-730

CD56 highCD16 - NK cell involvement in cutaneous lichen planus.

Carbone T; Nasorri F; Pennino D; Donnarumma M; Garcovich S; Eyerich K; Bergamo F; Cavani A
Article: JOURNAL OF RHEUMATOLOGY. 2010;37(7):1488-1501

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.

Avouac J; Walker U; Tyndall A; Kahan A; Matucci-Cerinic M; Allanore Y; EUSTAR; Miniati I; Muller A; Iannone F; Distler O; Becvar R; Sierakowsky S; Kowal-Bielecka O; Coelho P; Cabane J; Cutolo M; Shoenfeld Y; Valentini G; Rovensky J; Riemekasten G; Vlachoyiannopoulos P; Caporali R; Jiri S; Inanc M; Zimmermann Gorska I; Carreira P; Novak S; Czirjak L; Oliveira Ramos F; Jendro M; Chizzolini C; Kucharz EJ; Richter J; Cozzi F; Rozman B; Mallia CM; Gabrielli A; Farge D; Kiener HP; Schöffel D; Airo P; Wollheim F; Martinovic D; Trotta F; Jablonska S; Reich K; Bombardieri S; Siakka P; Pellerito R; Bambara LM; Morovic-Vergles J; Denton C; Hinrichs R; Van den Hoogen F; Damjanov N; Kötter I; Ortiz V; Heitmann S; Krasowska D; Seidel M; Hasler P; Van Laar JM; Kaltwasser JP; Foeldvari I; Juan Mas A; Bajocchi G; Wislowska M; Pereira Da Silva JA; Jacobsen S; Worm M; Graniger W; Kuhn A; Stankovic A; Cossutta R; Majdan M; Damjanovska Rajcevska L; Tikly M; Nasonov EL; Steinbrink K; Herrick A; Müller-Ladner U; Dinc A; Scorza R; Sondergaard K; Indiveri F; Nielsen H; Szekanecz Z; Silver RM; Antivalle M; Espinosa IB; García de la Pena Lefebvre P; Midtvedt O; Launay D; Valesini F; Tuvik P; Ionescu RM; Del Papa N; Pinto S; Wigley F; Mihai C; Sinziana Capranu M; Sunderkötter C; Jun JB; Alhasani S; Distler JH; Ton E; Soukup T; Seibold J; Zeni S; Nash P; Mouthon L; De Keyser F; Duruöz MT; Cantatore FP; Strauss G; von Mülhen CA; Pozzi MR; Eyerich K; Szechinski J; Keiserman M; Houssiau FA; Román-Ivorra JA; Krummel-Lorenz B; Aringer M; Westhovens R; Bellisai F; Mayer M; Stoeckl F; Uprus M; Volpe A; Buslau M; Yavuz S; Granel B; Valderílio Feijó A; Del Galdo F; Popa S; Zenone T; Ricardo Machado X; Pileckyte M; Stebbings S; Mathieu A; Tulli A; Tourinho T; Souza R; Acayaba de Toledo R; Stamp L; Solanki K; Veale D; Francisco Marques Neto J; Bagnato GF; Loyo E; Toloza S; Li M; Ahmed Abdel Atty Mohamed W; Cobankara V; Olas J; Salsano F; Oksel F; Tanaseanu CM; Foti R; Ancuta C; Vonk M; Caramashi P; Beretta L; Balbir A; Chiàla A; Pasalic Simic K; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Hachulla E; Furst DE
Article: EXPERIMENTAL DERMATOLOGY. 2010;19(6):511-517

Comparative in situ topoproteome analysis reveals differences in patch test-induced eczema: cytotoxicity-dominated nickel versus pleiotrope pollen reaction.

Eyerich K; Böckelmann R; Pommer AJ; Foerster S; Hofmeister H; Huss-Marp J; Cavani A; Behrendt H; Ring J; Gollnick H; Bonnekoh B; Traidl-Hoffmann C
Article: JOURNAL OF IMMUNOLOGY. 2010;184(9):4880-4888

IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes.

Pennino D; Eyerich K; Scarponi C; Carbone T; Eyerich S; Nasorri F; Garcovich S; Traidl-Hoffmann C; Albanesi C; Cavani A
Article: JOURNAL OF IMMUNOLOGY. 2010;184(2):1102-1110

CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses.

Carbone T; Nasorri F; Pennino D; Eyerich K; Foerster S; Cifaldi L; Traidl-Hoffman C; Behrendt H; Cavani A
Article: JOURNAL OF CLINICAL INVESTIGATION. 2009;119(12):3573-3585

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Eyerich S; Eyerich K; Pennino D; Carbone T; Nasorri F; Pallotta S; Cianfarani F; Odorisio T; Traidl-Hoffmann C; Behrendt H; Durham SR; Schmidt-Weber CB; Cavani A
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009;123(1):59-66.e4

IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response.

Eyerich K; Pennino D; Scarponi C; Foerster S; Nasorri F; Behrendt H; Ring J; Traidl-Hoffmann C; Albanesi C; Cavani A
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2008;128(11):2640-2645

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

Eyerich K; Foerster S; Rombold S; Seidl H-P; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
Article: INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2008;145(3):213-223

Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients.

Eyerich K; Huss-Marp J; Darsow U; Wollenberg A; Foerster S; Ring J; Behrendt H; Traidl-Hoffmann C
Article: DERMATOLOGY. 2008;217(1):52-55

Lipomatous metaplasia after severe and chronic cutaneous inflammation.

Eyerich K; Traidl-Hoffmann C; Albert A; Kerzl R; Rombold S; Darsow U; Eberlein B; Jakob T; Ring J; Hein R
Article: ARCHIVES OF DERMATOLOGICAL RESEARCH. 2007;299(10):475-481

Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.

Eyerich K; Rombold S; Foerster S; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
Article: INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2006;140(3):239-244

Modulation of atopy patch test and skin prick test by pretreatment with 1% pimecrolimus cream.

Weissenbacher S; Traidl-Hoffmann C; Eyerich K; Katzer K; Braeutigam M; Loeffler H; Hofmann H; Behrendt H; Ring J; Darsow U
Show more

All other publications

Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2024;144(1):3-4

Back to Broad? How Molecular Profiling Facilitates Targeted Therapies of Overlapping Phenotypes.

Eyerich K; Garzorz-Stark N
Letter: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023;37(12):e1375-e1379

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.

Armstrong A; Eyerich K; Conrad C; Zhu Y; Yang Y-W; Miller M; You Y; Shen Y-K; Foley P; Griffiths CEM; Strober B
Review: DERMATOLOGY AND THERAPY. 2023;13(12):3031-3042

Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review.

Blauvelt A; Langley RG; Gordon KB; Silverberg JI; Eyerich K; Sommer MOA; Felding J; Warren RB
Editorial comment: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023;37(12):2401-2402

Iatrogenic switch from psoriasis to eczema: What does it mean and is it predictable?

Eyerich S; Eyerich K
Corrigendum: MICROBIOME. 2023;11(1):206

Correction: Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour.

Amar Y; Rogner D; Silva RL; Foesel BU; Ud-Dean M; Lagkouvardos I; Steimle-Grauer SA; Niedermeier S; Kublik S; Jargosch M; Heinig M; Thomas J; Eyerich S; Wikström JD; Schloter M; Eyerich K; Biedermann T; Köberle M
Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2023;143(7):1306-1309.e4

Baricitinib Blocks Cytokine-Mediated Downregulation of PAD1 in Human Keratinocytes: A Possible Molecular Link to the Effects of JAK Inhibitors in Atopic Dermatitis.

Padhi A; Rekha RS; Benrejdal L; Grundeken ME; Lourda M; Ehrström M; Eyerich K; Páez IT; Johansson EK; Bradley M; Bergman P; Lysell J
Review: BASIC RESEARCH IN CARDIOLOGY. 2023;118(1):18

Matrix metalloproteinases in coronary artery disease and myocardial infarction.

Bräuninger H; Krüger S; Bacmeister L; Nyström A; Eyerich K; Westermann D; Lindner D
Review: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023;21(5):445-453

Eczematized psoriasis - a frequent but often neglected variant of plaque psoriasis.

Lauffer F; Eyerich K
Review: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023;21(4):415-419

[Status quo und Zukunftsperspektiven der molekularen Diagnostik in der Dermatologie].

Gebhardt C; Eyerich K; Garzorz-Stark N
Review: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023;21(4):415-418

Status quo and future perspectives of molecular diagnostics in dermatology.

Gebhardt C; Eyerich K; Garzorz-Stark N
Review: AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2023;191(3):684-689

Autosomal dominant inheritance with sex-limited manifestation: An unusual mode of transmission in humans and animals.

Happle R; Eyerich K
Review: ALLERGY. 2023;78(1):84-120

Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review.

Broderick C; Ziehfreund S; van Bart K; Arents B; Eyerich K; Weidinger S; Rastrick J; Zink A; Flohr C; BIOMAP Consortium
Review: LIFE-BASEL. 2022;12(12):2026

The Impact of Psoriasis and Atopic Dermatitis on Quality of Life: A Literature Research on Biomarkers.

Balato A; Zink A; Babino G; Buononato D; Kiani C; Eyerich K; Ziehfreund S; Scala E
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2022;20(10):1362-1364

Erfolgreiche Therapie einer akuten generalisierten pustulösen Psoriasis mit dem IL-23p19-Antikörper Risankizumab.

Heyer S; Seiringer P; Eyerich S; Pilz AC; Steimle-Grauer SA; Eyerich K; Biedermann T; Böhner A
Review: BRITISH JOURNAL OF DERMATOLOGY. 2022;187(4):494-506

Biomarkers of systemic treatment response in people with psoriasis: a scoping review.

Corbett M; Ramessur R; Marshall D; Acencio ML; Ostaszewski M; Barbosa IA; Dand N; Di Meglio P; Haddad S; Jensen AHM; Koopmann W; Mahil SK; Rahmatulla S; Rastrick J; Saklatvala J; Weidinger S; Wright K; Eyerich K; Barker JN; Ndlovu M; Conrad C; Skov L; Smith CH; BIOMAP consortium
Review: BRITISH JOURNAL OF DERMATOLOGY. 2022;187(4):481-493

Biomarkers of disease progression in people with psoriasis: a scoping review.

Ramessur R; Corbett M; Marshall D; Acencio ML; Barbosa IA; Dand N; Di Meglio P; Haddad S; Jensen AHM; Koopmann W; Mahil SK; Ostaszewski M; Rahmatulla S; Rastrick J; Saklatvala J; Weidinger S; Wright K; Eyerich K; Ndlovu M; Barker JN; Skov L; Conrad C; Smith CH; BIOMAP consortium
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2022;20(10):1362-1364

Acute generalized pustular psoriasis successfully treated with the IL-23p19 antibody risankizumab.

Heyer S; Seiringer P; Eyerich S; Pilz AC; Steimle-Grauer SA; Eyerich K; Biedermann T; Böhner A
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2022;20(9):1233-1235

Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV-Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen.

Bentz P; Eyerich K; Weisshaar E
Review: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(3 Pt B):804-810

T-Cell‒Mediated Autoimmunity: Mechanisms and Future Directions.

Seiringer P; Garzorz-Stark N; Eyerich K
Review: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2022;23(Suppl 1):5-12

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis.

Zheng M; Jullien D; Eyerich K
Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(1):14-15

IFN-1s: Sentinels Shaping Distinct Immune Responses in Skin.

Garzorz-Stark N; Eyerich K
Review: EXPERIMENTAL DERMATOLOGY. 2021;30(10):1517-1531

The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseases.

Alenius H; Sinkko H; Moitinho-Silva L; Rodriguez E; Broderick C; Alexander H; Reiger M; Hjelmsø MH; Fyhrquist N; Olah P; Bryce P; Smith C; Koning F; Eyerich K; Greco D; van den Bogaard EH; Neumann AU; Traidl-Hoffmann C; Homey B; Flohr C; Bønnelykke K; Stokholm J; Weidinger S
Review: CELLS. 2021;10(8):2094

Hidradenitis Suppurativa: Where We Are and Where We Are Going.

Scala E; Cacciapuoti S; Garzorz-Stark N; Megna M; Marasca C; Seiringer P; Volz T; Eyerich K; Fabbrocini G
Review: JOURNAL OF INTERNAL MEDICINE. 2021;290(1):27-39

So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.

Schäbitz A; Eyerich K; Garzorz-Stark N
Editorial comment: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2021;19(5):782-784

Multiple pustular lesions in a patient with ulcerative colitis - successfully treated with TNF-alpha-inhibitor.

Boehmer DF; Möckel S; Eyerich K; Biedermann T; Posch C
Editorial comment: HAUTARZT. 2021;72(4):354-357

[Cohort study for long-term follow-up of patients in whom the so-called "molecular classifier" is used to distinguish eczema from psoriasis : Background and implementation].

Bentz P; Eyerich K; Weber K; Kluge L; Ofenloch R; Weisshaar E
Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2021;141(3):681-685.e6

CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis.

Thomas J; Wang R; Batra R; Böhner A; Garzorz-Stark N; Eberlein B; Theis F; Biedermann T; Schmidt-Weber C; Zink A; Eyerich K; Eyerich S
Letter: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(3):e189-e192

Transferability of suggested molecular classifiers for psoriasis and eczema to the Chinese population.

Xu M-N; Li L; Pan W; Dai S-Q; Wang Q; Wang M-L; Zeng K; Huang X-W; Eyerich K
Editorial comment: ALLERGY. 2020;75(11):3003-3006

Medical algorithm: Diagnosis and treatment of hypereosinophilic syndrome.

Schuster B; Zink A; Eyerich K
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(8):1123-1125

Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Hughes M; Heal C; Siegert E; Hachulla E; Airó P; Riccardi A; Distler O; Matucci-Cerinic M; EUSTAR Collaborators
Review: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2020;18(8):795-809

COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen

Schön MP; Berking C; Biedermann T; Buhl T; Erpenbeck L; Eyerich K; Eyerich S; Ghoreschi K; Goebeler M; Ludwig RJ; Schäkel K; Schilling B; Schlapbach C; Stary G; von Stebut E; Steinbrink K
Letter: EMERGING INFECTIOUS DISEASES. 2020;26(8):1935-1937

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany.

Hijnen D; Marzano AV; Eyerich K; GeurtsvanKessel C; Giménez-Arnau AM; Joly P; Vestergaard C; Sticherling M; Schmidt E
Review: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2020;18(8):795-807

COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.

Schön MP; Berking C; Biedermann T; Buhl T; Erpenbeck L; Eyerich K; Eyerich S; Ghoreschi K; Goebeler M; Ludwig RJ; Schäkel K; Schilling B; Schlapbach C; Stary G; von Stebut E; Steinbrink K
Editorial comment: ACTA DERMATO-VENEREOLOGICA. 2020;100(14):adv00220

Tofacitinib in Hypertrophic Lichen Planus.

Seiringer P; Lauffer F; Pilz AC; Boehmer D; Biedermann T; Eyerich K
Review: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2020;18(7):675-681

Cytokines of the IL-17 family in psoriasis.

Lauffer F; Eyerich K; Boehncke W-H; Asadullah K; Beissert S; Ghoreschi K; Schön MP
Editorial comment: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020;145(4):1138-1141

Biologics in the treatment of skin and rheumatologic diseases.

Kahlenberg JM; Billi AC; Eyerich K; Gudjonsson JE
Review: ALLERGY. 2020;75(3):546-560

New biological treatments for asthma and skin allergies.

Eyerich S; Metz M; Bossios A; Eyerich K
Editorial comment: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2020;34(1):11-12

Assessing genotypes to predict therapeutic outcome in psoriasis.

Eyerich K
Review: INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2020;181(5):321-333

Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Maurer M; Eyerich K; Eyerich S; Ferrer M; Gutermuth J; Hartmann K; Jakob T; Kapp A; Kolkhir P; Larenas-Linnemann D; Park H-S; Pejler G; Sánchez-Borges M; Schäkel K; Simon D; Simon H-U; Weller K; Zuberbier T; Metz M
Letter: JAMA DERMATOLOGY. 2019;155(12):1424-1426

Treatment of Pityriasis Rubra Pilaris With Guselkumab.

Pilz AC; Seiringer P; Biedermann T; Eyerich K
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2019;17(11):1165-1167

Erfolgreiche Behandlung eines schweren dyshidrosiformen Ekzems mit Dupilumab bei einem Kind

Weins AB; Biedermann T; Eyerich K; Moeckel S; Schnopp C
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2019;17(11):1165-1167

Successful treatment of recalcitrant dyshidrotic eczema with dupilumab in a child.

Weins AB; Biedermann T; Eyerich K; Moeckel S; Schnopp C
Editorial comment: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;144(5):1175-1176

Counteracting lipids orchestrate type 2 immunity.

Eyerich K
Editorial comment: HAUTARZT. 2019;70(10):752-754

[Hand eczema: still a diagnostic and therapeutic challenge].

Weisshaar E; Eyerich K
Review: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2019;33(6):1051-1061

Non-invasive imaging in dermatology and the unique potential of raster-scan optoacoustic mesoscopy.

Hindelang B; Aguirre J; Schwarz M; Berezhnoi A; Eyerich K; Ntziachristos V; Biedermann T; Darsow U
Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2019;139(5):995-996

Psoriasis Pathogenesis: Keratinocytes Are Back in the Spotlight.

Garzorz-Stark N; Eyerich K
Editorial comment: HAUTARZT. 2019;70(1):4

[Personalized medicine].

Eyerich K; Tüting T
Review: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;143(1):36-45

Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council.

Eyerich K; Brown SJ; Perez White BE; Tanaka RJ; Bissonette R; Dhar S; Bieber T; Hijnen DJ; Guttman-Yassky E; Irvine A; Thyssen JP; Vestergaard C; Werfel T; Wollenberg A; Paller AS; Reynolds NJ
Editorial comment: HAUTARZT. 2018;69(Suppl 2):105-108

[46/f with itchy skin lesions in seborrheic areas : Preparation for the specialist examination: part 7].

Boehmer D; Eyerich K
Review: EXPERIMENTAL DERMATOLOGY. 2018;27(10):1067-1077

Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.

Boehner A; Navarini AA; Eyerich K
Other: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(10):1278-1281

Muskelhypertrophie und Onychodystrophie.

Mattjie RA; Kelenjian S; Haas T; Biedermann T; Eyerich K
Editorial comment: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(10):1278-1281

Muscle hypertrophy and onychodystrophy.

Mattjie RA; Kelenjian S; Haas T; Biedermann T; Eyerich K
Editorial comment: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(8):963-964

Atopisches Ekzem: die Basis nicht vergessen!

Eyerich K
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(7):907-910

Ixekizumab for acrodermatitis continua.

Pilz AC; Roenneberg S; Biedermann T; Eyerich K
Letter: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(7):907-910

Ixekizumab gegen die Acrodermatitis continua.

Pilz AC; Roenneberg S; Biedermann T; Eyerich K
Review: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2018;32(5):692-703

Immune response patterns in non-communicable inflammatory skin diseases.

Eyerich K; Eyerich S
Review: TRENDS IN IMMUNOLOGY. 2018;39(4):315-327

Cutaneous Barriers and Skin Immunity: Differentiating A Connected Network.

Eyerich S; Eyerich K; Traidl-Hoffmann C; Biedermann T
Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2018;138(3):711-714

STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.

Hiller J; Hagl B; Effner R; Puel A; Schaller M; Mascher B; Eyerich S; Eyerich K; Jansson AF; Ring J; Casanova J-L; Renner ED; Traidl-Hoffmann C
Other: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(1):96-98

Rezidivierende Ohrschwellung.

Chylla R; Hein R; Biedermann T; Eyerich K
Editorial comment: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2018;16(1):96-98

Recurrent swelling of the ear.

Chylla R; Hein R; Biedermann T; Eyerich K
Review: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2017;31(11):1792-1799

European consensus statement on phenotypes of pustular psoriasis.

Navarini AA; Burden AD; Capon F; Mrowietz U; Puig L; Köks S; Kingo K; Smith C; Barker JN; ERASPEN Network
Review: EUROPEAN JOURNAL OF IMMUNOLOGY. 2017;47(4):607-614

IL-17 and IL-22 in immunity: Driving protection and pathology.

Eyerich K; Dimartino V; Cavani A
Editorial comment: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2017;31(3):388

DMARDs in psoriasis: a critical appraisal.

Eyerich K
Review: ALLERGOL SELECT. 2017;1(1):71-76

Novel key cytokines in allergy: IL-17, IL-22.

Eyerich S; Traidl-Hoffmann C; Behrendt H; Cavani A; Schmidt-Weber CB; Ring J; Eyerich K
Review: ANAIS BRASILEIROS DE DERMATOLOGIA. 2017;92(1):72-80

Skin symptoms as diagnostic clue for autoinflammatory diseases.

Moreira A; Torres B; Peruzzo J; Mota A; Eyerich K; Ring J
Review: MMW FORTSCHRITTE DER MEDIZIN. 2016;158(15):55-60

[Diabetes and skin].

de Béchade T; Eyerich K
Editorial comment: ALLERGY. 2016;71(5):588-592

Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine.

Bieber T; Akdis C; Lauener R; Traidl-Hoffmann C; Schmid-Grendelmeier P; Schäppi G; Allam J-P; Apfelbacher C; Augustin M; Beck L; Biedermann T; Braun-Fahrländer C; Chew FT; Clavel T; Crameri R; Darsow U; Deleuran M; Dittlein D; Duchna H-W; Eichenfeld L; Eyerich K; Frei R; Gelmetti C; Gieler U; Gilles S; Glatz M; Grando K; Green J; Gutermuth J; Guttman-Yassky E; Hanifin J; Hijnen D; Hoetzenecker W; Irvine A; Kalweit A; Katoh N; Knol E; Koren H; Möhrenschlager M; Münch D; Novak N; O'Mahony L; Paller AS; Rhyner C; Roduit C; Schiesser K; Schröder J; Simon D; Simon H-U; Sokolowska M; Spuls P; Stalder J-F; Straub D; Szalai Z; Taieb A; Takaoka R; Todd G; Todorova A; Vestergaard C; Werfel T; Wollenberg A; Ring J
Letter: JAMA DERMATOLOGY. 2016;152(4):482-484

Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.

Böhner A; Roenneberg S; Eyerich K; Eberlein B; Biedermann T
Letter: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2016;30(1):141-143

Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?

Garzorz N; Papanagiotou V; Atenhan A; Andres C; Eyerich S; Eyerich K; Ring J; Brockow K
Review: TRENDS IN IMMUNOLOGY. 2015;36(12):788-801

The Multi-Modal Immune Pathogenesis of Atopic Eczema.

Eyerich K; Eyerich S; Biedermann T
Editorial comment: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2015;11(2):167-169

NOS2 and CCL27: clinical implications for psoriasis and eczema diagnosis and management.

Garzorz N; Eyerich K
Review: ALLERGO JOURNAL INTERNATIONAL. 2015;24(1):1-7

Th22 cells in allergic disease.

Eyerich K; Eyerich S
Editorial comment: ALLERGY. 2014;69(8):978-982

Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure--challenges and actions to be taken.

Ring J; Akdis C; Lauener R; Schäppi G; Traidl-Hoffmann C; Akdis M; Ammann W; Behrendt H; Bieber T; Biedermann T; Bienenstock J; Blaser K; Braun-Fahrländer C; Brockow K; Buters J; Crameri R; Darsow U; Denburg JA; Eyerich K; Frei R; Galli SJ; Gutermuth J; Holt P; Koren H; Leung D; Müller U; Muraro A; Ollert M; O'Mahony L; Pawankar R; Platts-Mills T; Rhyner C; Rosenwasser LJ; Schmid-Grendelmeier P; Schmidt-Weber CB; Schmutz W; Simon D; Simon HU; Sofiev M; van Hage M; van Ree R
Review: ALLERGY. 2013;68(8):974-982

Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.

Eyerich K; Novak N
Review: TRENDS IN IMMUNOLOGY. 2010;31(9):354-361

IL-17 and IL-22: siblings, not twins.

Eyerich S; Eyerich K; Cavani A; Schmidt-Weber C
Review: DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. 2010;135(27):1379-1388

[Mucocutaneous candidiasis].

Traidl-Hoffmann C; Eyerich K; Maier E; Behrendt H; Ring J; Hofmann H
Review: EUROPEAN JOURNAL OF DERMATOLOGY. 2010;20(3):260-265

Chronic mucocutaneous candidiasis, from bench to bedside.

Eyerich K; Eyerich S; Hiller J; Behrendt H; Traidl-Hoffmann C
Letter: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2009;23(2):224-226

Parallel occurrence of Erdheim-Chester disease and eosinophilic granuloma in the same patient.

Kerzl R; Eyerich K; Eberlein B; Hein R; Weichenmeier I; Behrendt H; Clemm C; Fend F; Mempel S; Waldt S; Ring J; Mempel M
Letter: EUROPEAN JOURNAL OF DERMATOLOGY. 2009;19(1):78-79

Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I.

Eyerich K; Cifaldi L; Notarangelo LD; Porta F; Notarangelo L; Mazzolari E; Fiorini M; Paradisi A; Cavani A
Show more

About me

Articles

All other publications

News from KI

Events from KI